Tag Archives: access to medicines
By Casey McDonald | Published: November 12, 2014
Merck KGaA CEO Stefan Oschmann spoke last week in New York as he accepted the two-year role as president of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the R&D industry’s global trade group based in Geneva.
By William Looney | Published: October 6, 2010
Just who are those “bottom billion” potential consumers in developing countries? A new report sheds some light. Big Pharma’s future depends on tapping new sources of business opportunity. One segment on virtually everyone’s must do list is the “bottom billion”—poor consumers in the world’s poorer countries. Market analysis suggests that when the bottom billion’s potential […]